How GLP-1 Medications Support Medical Weight Loss

July 31, 2026

Struggling to lose weight even when doing everything right? For many adults, the issue is physiological, not willpower, and GLP-1 medications are among the most clinically supported tools available today. This post explains how semaglutide and tirzepatide work, who qualifies, and what provider-guided GLP-1 care looks like at A New Way Healthcare in Jacksonville Beach.


What Are GLP-1 Medications?


GLP-1 medications are prescription receptor agonists that mimic the body's natural hunger-regulating hormone to reduce appetite, slow digestion, and support blood sugar control. They are administered as weekly injections and include semaglutide and tirzepatide.


GLP-1 receptor agonist medications are designed to mimic this hormone, amplifying its effects in a sustained and controlled way. Clinical research on GLP-1 receptor agonists produce meaningful reductions in body weight by targeting the brain's appetite regulation pathways, not just caloric intake.


The two most widely recognized medications in this class are semaglutide and tirzepatide. Each works through a slightly different mechanism, and a provider determines which option is the right fit based on individual health history, goals, and response to treatment.


How Semaglutide Works for Weight Loss


Semaglutide for weight loss: the clinical mechanism


Semaglutide for weight loss works by activating GLP-1 receptors in the brain, specifically in areas responsible for hunger and reward signaling. The result is a significant reduction in appetite and a greater sense of fullness after eating smaller amounts of food.


Clinical trials published through the National Institutes of Health showed participants using semaglutide alongside lifestyle changes lost a meaningful percentage of body weight over 68 weeks, with sustained results when treatment continued under medical oversight.


Semaglutide is delivered as a subcutaneous injection, typically once per week. The dose is increased gradually over several weeks to help the body adjust and minimize common side effects such as nausea or digestive discomfort.


How tirzepatide medical weight loss differs


Tirzepatide medical weight loss treatment takes a dual-action approach. Unlike semaglutide, which targets GLP-1 receptors alone, tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously.


This dual mechanism has shown even greater reductions in body weight in some clinical studies. Whether semaglutide or tirzepatide is the right choice depends entirely on the individual. Both are available through a provider-supervised weight loss program where dosing and monitoring are personalized to the patient. 


Who Is a Good Candidate for GLP-1 Therapy?


GLP-1 therapy is not a one-size-fits-all solution, and it's not appropriate for everyone. At A New Way Healthcare, candidacy is assessed through a thorough intake conversation and clinical review.


Generally speaking, candidates are adults who meet one or more of the following criteria:


  • A body mass index of 30 or higher
  • A BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, prediabetes, or elevated cholesterol
  • A history of difficulty losing or maintaining weight through lifestyle changes alone
  • No contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2


Eligibility is always determined by your care team after a full clinical review. If you have questions about whether this treatment is right for you, the FAQ page covers common candidacy questions in more detail.


Common Side Effects and How They're Managed


What to know about GLP-1 side effects before you start


Most people who begin GLP-1 therapy will experience some degree of side effects, particularly in the first few weeks. This is normal, and it is one of the core reasons that provider supervision matters throughout the entire process, not just at the start.


The most commonly reported side effects include nausea, constipation, vomiting, and loss of appetite. These tend to appear within the first one to two weeks of starting therapy and are typically most noticeable in the days following a dose adjustment. For the majority of patients, these symptoms are mild and begin to ease as the body adapts, usually within two to four weeks.


Severity can vary. Most patients experience mild and manageable discomfort. Serious side effects are uncommon but do exist, and knowing when to reach out to your provider is part of the program from day one.


Managing side effects often comes down to a few practical adjustments:


Eating smaller, slower meals can reduce nausea significantly, especially in the first few weeks. Staying well hydrated supports digestion and helps ease constipation that some patients notice at the start. In some cases, a temporary dose adjustment is the most effective approach, and your clinician will make that call based on how your body is responding, not on a fixed schedule.


At A New Way Healthcare, Ana Stauch and the care team monitor for these responses at every follow-up appointment. If something feels off between visits, patients are encouraged to reach out directly rather than waiting. That level of access is a defining feature of the practice model and it is especially relevant during the early weeks of GLP-1 therapy when the body is still adjusting.


When to contact your provider


Mild nausea that fades within a few hours is common and expected. You should contact the practice if you are experiencing persistent vomiting, significant abdominal pain, symptoms that are worsening rather than improving, or anything that feels outside the range of what was discussed at your initial consultation. Your clinician will advise you on next steps.


Side effect management is not an afterthought here. It is built into how the program works.


Medical Weight Loss vs. Going It Alone


Unsupervised use of GLP-1 medications, including compounded versions purchased through online platforms without clinical oversight, carries meaningful risks. Dosing errors, inadequate monitoring, and the absence of a clinical relationship mean that problems can go undetected and unaddressed.


A provider-guided approach is fundamentally different. Your clinician is monitoring you, not just prescribing.Without a clinical relationship, dosing errors or missed contraindications can go unaddressed, putting both safety and outcomes at risk.


Florida residents who access GLP-1 medications through a provider-supervised care plan at a qualified clinic also benefit from built-in accountability structures that support sustainable outcomes. Studies suggest that patients enrolled in supervised programs tend to achieve better results and sustain them longer than those who attempt treatment without clinical support.


If you're curious about what a structured program looks like versus navigating this on your own, the about page shares more about how care is approached at A New Way Healthcare.


GLP-1 Therapy at A New Way Healthcare


Integrative, Patient-Centered GLP-1 Care


GLP-1 therapy Jacksonville FL patients receive through A New Way Healthcare is grounded in integrative medicine. That means the conversation goes beyond the scale. Hormonal health, gut function, stress, sleep, and nutrition all influence weight, and they're all part of how care is delivered here.


Ana Stauch, ARNP, leads the clinical work with an emphasis on understanding the root causes behind why a patient is struggling, not just addressing the symptom. GLP-1 medications are one clinical tool. They're most effective when they're part of a plan that addresses the full picture.


The primary care health plans available through A New Way Healthcare also make it possible for patients to access ongoing, coordinated care without the friction of a traditional insurance-driven system.


Exploring GLP-1 and Medical Weight Loss Options in Jacksonville Beach


GLP-1 medications medical weight loss treatment has clinical evidence behind it, but it works best when it's delivered through a care relationship built on trust and individualized attention. GLP-1 therapy is most effective when it is part of a personalized plan that accounts for your full health history, not just your weight.


If you're in the Jacksonville Beach area and want to understand your options, the team at A New Way Healthcare is here to help you sort through the clinical picture and find a path that makes sense for your health.


Take the Next Step Toward Provider-Guided Weight Loss


If GLP-1 therapy sounds like it could be the right fit, the best next step is a conversation with the care team. Visit the medical weight management program or call (904) 299-0373 to get started.


Frequently Asked Questions


1. How does semaglutide help with weight loss?


Semaglutide activates GLP-1 receptors in the brain, reducing hunger signals and increasing feelings of fullness after eating. When combined with clinical oversight and lifestyle support, it can produce significant, sustained reductions in body weight.


2. bWhat is GLP-1 and how does it work?


GLP-1 is a hormone naturally released by the gut after eating. It signals fullness to the brain, slows gastric emptying, and supports insulin release. GLP-1 receptor agonist medications replicate and amplify these effects in a sustained way.


3. Is GLP-1 therapy safe for weight loss?


When prescribed and monitored by a qualified clinician, GLP-1 therapy has a well-established safety profile. Side effects are most common early in treatment and typically improve as the body adjusts. Clinical monitoring is essential for identifying and managing any issues.


4. How long does it take to lose weight on semaglutide?


Most patients notice reduced appetite within the first two to four weeks. Meaningful weight changes are typically observed over three to six months of consistent treatment. Individual results vary based on dosing, adherence, and overall health.


5. Who qualifies for GLP-1 weight loss medication?


Candidacy is based on BMI, the presence of weight-related health conditions, and a review of personal and family health history. A full clinical evaluation is required before any medication is prescribed.


6. Can I get GLP-1 medications without a provider?


Some compounded or online-dispensed versions are available, but using GLP-1 medications without clinical oversight significantly increases risk. Dosing errors, missed contraindications, and the absence of monitoring are serious concerns. Provider-supervised access is the recommended and safer path.


Key Takeaways

  • GLP-1 medications are prescription treatments that reduce appetite and support blood sugar regulation through hormone-mimicking action
  • Semaglutide for weight loss and tirzepatide medical weight loss are the two primary medications in this class, with tirzepatide offering a dual-receptor mechanism
  • Clinical supervision is not optional. A provider-supervised weight loss program ensures dosing is correct, side effects are managed, and progress is monitored
  • GLP-1 therapy at A New Way Healthcare is part of an integrative care model that addresses root-cause factors like hormonal health, gut function, and stress, not weight in isolation
  • Provider-supervised GLP-1 care includes built-in accountability and clinical monitoring, which research shows improves both outcomes and long-term sustainability
  • Candidacy is determined through a full clinical review. Not everyone is an appropriate candidate, and that assessment protects both safety and effectiveness
By Ana Stauch • October 15, 2026
Your Annual Screening Is a Starting Point October is Breast Cancer Awareness Month, and every year the message is familiar: schedule your mammogram. And that matters. Mammography remains one of the most effective tools for early detection, and staying current on your screenings is one of the most important things you can do for your breast health. But for many women, the mammogram is where the conversation begins and ends. You schedule it, you get through it, you wait for results, you move on. And unless something comes back abnormal, breast health doesn't come up again until the following year. The reality is that a complete breast health strategy involves more than a single annual screening. It includes understanding your individual risk factors, knowing your breast density, making informed nutrition and lifestyle choices, and having honest conversations with your healthcare provider about what proactive care looks like for your specific body. Breast Density: The Variable Most Women Miss If you've never been told your breast density category, you're in good company. Many women go years without knowing this information, even though it directly affects both their risk level and the accuracy of their mammograms. Breast density refers to the proportion of fibrous and glandular tissue relative to fatty tissue. It's determined by mammogram, not by breast size or how your breasts feel on self-exam. Roughly 40-50% of women in screening age ranges have dense breast tissue, which falls into categories C or D on the four-tier scale. Why this matters: dense breast tissue is associated with increased breast cancer risk on its own. And because both dense tissue and tumors appear white on a mammogram, standard 2D imaging may miss abnormalities that would be visible in less dense tissue. For women with dense breasts, supplemental screening like breast ultrasound or MRI may significantly improve detection. If you don't know your breast density, ask. If you're category C or D, ask your healthcare provider whether additional screening is appropriate for you. Risk Factors: What You Can't Change and What You Can Some breast cancer risk factors are fixed. Family history, genetic mutations like BRCA1 and BRCA2, age at first period, and age at menopause all play a role. If you have a first-degree relative who was diagnosed, your risk is roughly doubled compared to someone without that family history. Knowing where you stand with these factors helps your healthcare provider tailor your screening schedule and monitoring approach. But a meaningful portion of your risk profile is shaped by choices you make every day. Regular physical activity, 150 or more minutes per week of moderate exercise, is associated with a 10-20% reduction in breast cancer risk. Even moderate alcohol consumption, around one drink per day, increases risk by 7-10%. Body composition, sleep quality, and chronic stress all contribute. This is not about perfection. It's about being intentional with the factors you can actually influence, and knowing which ones are worth prioritizing. Nutrition as a Layer of Prevention There is no single food that prevents breast cancer. But dietary patterns matter. Cruciferous vegetables like broccoli, cauliflower, and Brussels sprouts contain compounds that support healthy estrogen metabolism. Omega-3 fatty acids from fish, walnuts, and flaxseed help manage inflammation. Vitamin D levels, frequently low and rarely checked, have been linked to breast cancer outcomes in multiple studies. On the other side, ultra-processed foods contribute to chronic inflammation. Endocrine disruptors found in certain plastics and personal care products can interfere with hormonal signaling over time. You don't need to overhaul your life overnight. But knowing where targeted changes can support your body's protective systems gives you more agency than most awareness campaigns offer. Hormone Therapy: Why Fear Shouldn't Be the Deciding Factor For women in perimenopause or menopause, the question of hormone therapy often carries more anxiety than almost any other health decision. And most of that anxiety traces back to a 2002 study that was widely interpreted as proof that hormones cause breast cancer. The full picture is more reassuring than the headlines ever suggested. The overall breast cancer risk associated with modern hormone therapy is low. The elevated risk reported in that original study was tied specifically to synthetic progestins, not to all forms of hormonal support. Body-identical progesterone, which is structurally the same as what your body produces naturally, has shown a different and more favorable safety profile in large-scale research. The type of hormone matters. The route of delivery matters. The timing of when therapy begins relative to menopause matters. These variables make the difference between a generalized fear and an informed, individualized decision. And for women with a personal history of breast cancer, the conversation is more nuanced than a simple "no." A breast cancer history does not automatically disqualify you from every form of hormonal support. Depending on the type of cancer, receptor status, time since treatment, and severity of symptoms, there may be options available to you. That evaluation requires coordination between your oncologist and a hormone health provider who understands the current evidence, but the door is not closed by default. Meanwhile, the consequences of going without hormonal support during menopause are real and well documented. Accelerated bone density loss, increased cardiovascular risk, cognitive changes, urogenital atrophy, and a significant reduction in quality of life. When weighing the risks of hormone therapy, the risks of avoidance deserve equal space in the conversation. If you've been putting off the hormone conversation because of what you heard years ago, the evidence has moved forward. Your decision should be based on your individual risk profile and the current research, not on a headline from 2002. What Proactive Care Looks Like Proactive breast health means knowing your breast density and what it means for your screening plan. It means understanding your individual risk factors, both the ones you carry and the ones you can influence. It means making nutrition and lifestyle choices that support your body's protective capacity. And it means having the conversations that matter, about screening, about risk, and about what your body actually needs during perimenopause and menopause. If you've been navigating menopause symptoms without exploring your hormone therapy options, or if you've avoided the conversation because of breast cancer concerns, this is a good time to revisit it with a healthcare provider who can walk through the evidence with you and assess your individual risk. Schedule a consultation to discuss your hormone health options, review your personal risk profile, and build a plan that reflects where your body is right now.
HORMONES spelled with letter tiles, with a stethoscope and medical tools on a desk
July 24, 2026
Discover the most common signs of hormone imbalance and learn when to get tested with provider care at A New Way Healthcare in Jacksonville Beach.